Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017101
University of California Sys Office/Pres, Oakland, CA, United States
Search grants from University of California Sys Office/Pres
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular Basis of Sexually Dimorphic Development of the Genital Tubercle
Morphogenesis and Function of the Cerebral Cortex
Dynamics and Kinetics of Protein Folding
Dynamics and Kinetics of Protein Folding
Graduate Research Fellowship Program
Recently added grants:
Surfactant Protein C Mouse Models: A Fit For Purpose Preclinical Platform For Advancing Discovery In And Treatment Of Idiopathic Pulmonary Fibrosis
The role of Ldb1 in regulating pancreatic islet cell delamination and differentiation
Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs
A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2)
Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017101-005
Application #
6828833
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of California Sys Office/Pres
Department
Type
DUNS #
003985512
City
Oakland
State
CA
Country
United States
Zip Code
94607
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
Comments
Be the first to comment on this grant